Cargando…
Association between the use of allopurinol and risk of increased thyroid-stimulating hormone level
Allopurinol is the first-line agent for patients with gout, including those with moderate‐to‐severe chronic kidney disease. However, increased thyroid-stimulating hormone (TSH) levels are observed in patients with long-term allopurinol treatment. This large-scale, nested case–control, retrospective...
Autores principales: | Choi, Wona, Yang, Yoon-Sik, Chang, Dong-Jin, Chung, Yeon Woong, Kim, HyungMin, Ko, Soo Jeong, Yoo, Sooyoung, Oh, Ji Seon, Kang, Dong Yoon, Yang, Hyeon-Jong, Choi, In Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514499/ https://www.ncbi.nlm.nih.gov/pubmed/34645831 http://dx.doi.org/10.1038/s41598-021-98954-1 |
Ejemplares similares
-
Synergistic Impacts of Alpinia oxyphylla Seed Extract and Allopurinol against Experimental Hyperuricemia
por: Sung, Yoon-Young, et al.
Publicado: (2022) -
Allopurinol-induced DRESS syndrome mimicking biliary obstruction
por: Choi, Hyung Gyu, et al.
Publicado: (2014) -
Thyroid Stimulating Hormone, Cognitive Impairment and Depression in an Older Korean Population
por: Kim, Jae-Min, et al.
Publicado: (2010) -
Economic Evaluation of Recombinant Human Thyroid Stimulating Hormone Stimulation vs. Thyroid Hormone Withdrawal Prior to Radioiodine Ablation for Thyroid Cancer: The Korean Perspective
por: Sohn, Seo Young, et al.
Publicado: (2015) -
Goitrogenic Anions, Thyroid-Stimulating Hormone, and Thyroid Hormone in Infants
por: Cao, Yang, et al.
Publicado: (2010)